Evidence map›Paper›PMID 38407606›Full record

ArticleChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery2024

PTEN hamartoma tumor syndrome: Clinical and genetic characterization in pediatric patients.

Jesús Martín-Valbuena, Nerea Gestoso-Uzal, María Justel-Rodríguez, María Isidoro-García, Elena Marcos-Vadillo, Sandra Milagros Lorenzo-Hernández, M Carla Criado-Muriel, Pablo Prieto-Matos

Open access · hybridAbstract read
In one paragraph

Article in Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Jesús Martín-ValbuenaDepartment of Pediatrics, University Hospital of Salamanca, Salamanca, Spain.ORCID 0009-0003-8387-2292
Nerea Gestoso-UzalInstitute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain.ORCID 0000-0002-9755-6739
María Justel-RodríguezDepartment of Pediatrics, University Hospital of Salamanca, Salamanca, Spain.ORCID 0009-0009-1891-5368
María Isidoro-GarcíaInstitute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain.ORCID 0000-0002-9013-9422
Elena Marcos-VadilloInstitute for Biomedical Research of Salamanca, IBSAL, Salamanca, Spain.ORCID 0000-0003-1016-8395
Sandra Milagros Lorenzo-HernándezClinical Biochemistry Department, University Hospital of Salamanca, Salamanca, Spain.
M Carla Criado-MurielDepartment of Pediatrics, University Hospital of Salamanca, Salamanca, Spain. mccriado@saludcastillayleon.es.ORCID 0000-0002-7082-8845
Pablo Prieto-MatosDepartment of Pediatrics, University Hospital of Salamanca, Salamanca, Spain.ORCID 0000-0003-2680-3285
Universidad de Salamanca · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe aim of this study was to provide a full characterization of a cohort of 11 pediatric patients diagnosed with PTEN hamartoma tumor syndrome (PHTS). PATIENTS AND

methodsEleven patients with genetic diagnostic of PHTS were recruited between February 2019 and April 2023. Clinical, imaging, demographic, and genetic data were retrospectively collected from their hospital medical history.

resultsRegarding clinical manifestations, macrocephaly was the leading sign, present in all patients. Frontal bossing was the most frequent dysmorphism. Neurological issues were present in most patients. Dental malformations were described for the first time, being present in 27% of the patients. Brain MRI showed anomalies in 57% of the patients. No tumoral lesions were present at the time of the study. Regarding genetics, 72% of the alterations were in the tensin-type C2 domain of PTEN protein. We identified four PTEN genetic alterations for the first time.

conclusionsPTEN mutations appear with a wide variety of clinical signs and symptoms, sometimes associated with phenotypes which do not fit classical clinical diagnostic criteria for PHTS. We recommend carrying out a genetic study to establish an early diagnosis in children with significant macrocephaly. This facilitates personalized monitoring and enables anticipation of potential PHTS-related complications.

Indexed as

Hamartoma Syndrome, MultiplePTEN PhosphohydrolaseAdolescentChildChild, PreschoolFemaleHumansInfantMaleMegalencephalyMutationRetrospective StudiesPTEN PhosphohydrolasePTEN protein, humanChildrenCowden syndromeGeneticsMacrocephaly

Identifiers

PMID38407606
PMCPMC11111493
OpenAlexW4392164362

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.